Additionally, Tfh2 cells were highly activated in SLE patients compared to the control group, as they had higher IL-4, IL-5, and IL-13 expressions and were better at inducing plasma cell differentiation of B cells in vitro (26). The gene discussed is IL5; the disease is systemic lupus erythematosus.